المؤلفون: Dubuisson, A, Fahrner, JE, Goubet, AG, Terrisse, S, Voisin, N, Bayard, C, Lofek, S, Drubay, D, Bredel, D, Mouraud, S, Susini, S, Cogdill, A, Rebuffet, L, Ballot, E, Jacquelot, N, de Montpreville, VT, Casiraghi, O, Radulescu, C, Ferlicot, S, Figueroa, DJ, Yadavilli, S, Waight, JD, Ballas, M, Hoos, A, Condamine, T, Parier, B, Gaudillat, C, Routy, B, Ghiringhelli, F, Derosa, L, Breuskin, I, Rouanne, M, Andre, F, Lebacle, C, Baumert, H, Wislez, M, Fadel, E, Cremer, I, Albiges, L, Geoerger, B, Scoazec, JY, Loriot, Y, Kroemer, G, Marabelle, A, Bonvalet, M, Zitvogel, L

المصدر: EMBO MOLECULAR MEDICINE. 13(1)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:145651258

المؤلفون: Chand D; Agenus (United States), Lexington, MA, United States., Savitsky DA; Agenus, Lexington, MA, United States., Krishnan S; Agenus (United States), Lexington, MA, United States., Mednick G; Agenus (United States), Lexington, MA, United States., Delepine C; Agenus (United States), Lexington, MA, United States., Garcia-Broncano P; Agenus (United States), Lexington, MA, United States., Soh KT; Agenus (United States), Lexington, MA, United States., Wu W; Agenus (United States), Lexington, MA, United States., Wilkens MK; Agenus (United States), Lexington, MA, United States., Udartseva O; Agenus (United States), Lexington, MA, United States., Vincent S; Agenus (United States), Lexington, MA, United States., Joshi B; Agenus (United States), Lexington, MA, United States., Keith JG; Agenus (United States), Lexington, MA, United States., Manrique M; Agenus (United States), Lexington, MA, United States., Marques M; Agenus (United States), Lexington, MA, United States., Tanne A; Agenus (United States), Lexington, MA, United States., Levey DL; Agenus (United States), Lexington, MA, United States., Han H; Translational Genomics Research Institute, Phoenix, AZ, United States., Ng S; TGEN, Phoenix, Arizona, United States., Ridpath J; Agenus (United States), Lexington, MA, United States., Huber O; Agenus (United States), Lexington, MA, United States., Morin B; Agenus Inc., Lexington, MA, United States., Galand C; Agenus (United States), Lexington, MA, United States., Bourdelais S; Agenus (United States), Lexington, MA, United States., Gombos RB; Agenus Inc., Lexington, MA, United States., Ward R; Agenus Inc, Lexington, MA, United States., Qin Y; Agenus (United States), Lexington, MA, United States., Waight JD; GlaxoSmithKline (United States), Collegeville, PA, United States., Costa MR; Agenus (United States), Lexington, MA, United States., Sebastian-Yague A; Agenus (United States), Cambridge, United Kingdom., Rudqvist NP; Agenus (United States), Lexington, MA, United States., Pupecka-Swider M; Agenus (United States), Cambridge, United Kingdom., Venkatraman V; Agenus (United States), Cambridge, United Kingdom., Slee A; Agenus (United States), Lexington, MA, United States., Patel JM; Agenus (United States), Lexington, MA, United States., Grossman JE; Agenus Inc., Lexington, MA, United States., Wilson NS; Agenus Inc., Lexington, MA, United States., Von Hoff DD; Translational Genomics Research Institute, Phoenix, United States., Stebbing J; Anglia Ruskin University, Cambridge, United Kingdom., Curiel TJ; Dartmouth Health and The Geisel Medical School at Dartmouth, Lebanon, NO, United States., Buell JS; Agenus Inc., Lexington, MA, United States., O'Day SJ; Agenus Inc., Lexington, MA, United States., Stein RB; Agenus (United States), Lexington, MA, United States.

المصدر: Cancer discovery [Cancer Discov] 2024 Jul 31. Date of Electronic Publication: 2024 Jul 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

المؤلفون: Worboys JD; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Vowell KN; GlaxoSmithKline, Collegeville, PA, USA., Hare RK; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Ambrose AR; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Bertuzzi M; Manchester Fungal Infection Group, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Conner MA; GlaxoSmithKline, Collegeville, PA, USA., Patel FP; GlaxoSmithKline, Collegeville, PA, USA., Zammit WH; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Gali-Moya J; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, South Kensington, London, UK., Hazime KS; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, South Kensington, London, UK., Jones KL; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Rey C; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Jonjic S; Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia., Rovis TL; Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia., Tannahill GM; GlaxoSmithKline, Stevenage, UK., Cruz De Matos GDS; GlaxoSmithKline, Stevenage, UK., Waight JD; GlaxoSmithKline, Collegeville, PA, USA., Davis DM; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK. d.davis@imperial.ac.uk.; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, South Kensington, London, UK. d.davis@imperial.ac.uk.

المصدر: Nature communications [Nat Commun] 2023 Aug 18; Vol. 14 (1), pp. 5016. Date of Electronic Publication: 2023 Aug 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Lymphocyte Activation* , Lymphocytes, Tumor-Infiltrating*, Humans ; Microscopy ; Receptors, Immunologic/genetics ; Signal Transduction

المؤلفون: Yadavilli S; GSK, Collegeville, Pennsylvania., Waight JD; GSK, Collegeville, Pennsylvania., Brett S; GSK, Stevenage, Hertfordshire, United Kingdom., Bi M; GSK, Collegeville, Pennsylvania., Zhang T; GSK, Collegeville, Pennsylvania., Liu YB; GSK, Collegeville, Pennsylvania., Ellis C; GSK, Collegeville, Pennsylvania., Turner DC; GSK, Collegeville, Pennsylvania., Hahn A; GSK, Collegeville, Pennsylvania., Shi H; GSK, Collegeville, Pennsylvania., Seestaller-Wehr L; GSK, Collegeville, Pennsylvania., Jing J; GSK, Collegeville, Pennsylvania., Xie Q; GSK, Collegeville, Pennsylvania., Shaik JS; GSK, Collegeville, Pennsylvania., Ji X; GSK, Collegeville, Pennsylvania., Gagnon R; GSK, Collegeville, Pennsylvania., Fieles W; GSK, Collegeville, Pennsylvania., Hook L; GSK, Stevenage, Hertfordshire, United Kingdom., Grant S; GSK, Stevenage, Hertfordshire, United Kingdom., Hopley S; GSK, Collegeville, Pennsylvania., DeYoung MP; GSK, Collegeville, Pennsylvania., Blackwell C; GSK, Collegeville, Pennsylvania., Chisamore M; Merck & Co., Inc., Rahway, New Jersey., Biddlecombe R; GSK, Stevenage, Hertfordshire, United Kingdom., Figueroa DJ; GSK, Collegeville, Pennsylvania., Hopson CB; GSK, Collegeville, Pennsylvania., Srinivasan R; GSK, Collegeville, Pennsylvania., Smothers J; GSK, Collegeville, Pennsylvania., Maio M; University of Siena and Center for Immuno-Oncology, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Rischin D; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Olive D; CRCM, Immunity and Cancer, Inserm, U1068, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, CNRS, UMR7258, Marseille, France., Paul E; GSK, Collegeville, Pennsylvania., Mayes PA; GSK, Collegeville, Pennsylvania., Hoos A; GSK, Collegeville, Pennsylvania., Ballas M; GSK, Collegeville, Pennsylvania.

المصدر: Cancer research communications [Cancer Res Commun] 2023 Aug 16; Vol. 3 (8), pp. 1564-1579. Date of Electronic Publication: 2023 Aug 16 (Print Publication: 2023).

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal*/pharmacology , Ambulatory Care Facilities*, Humans ; Animals ; Mice ; Immune Checkpoint Inhibitors ; Immunoglobulin G ; Inhibition, Psychological

المؤلفون: Alsaid H; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA. hasan.5.alsaid@gsk.com., Cheng SH; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Bi M; Immuno-Oncology Research Unit, GlaxoSmithKline, Collegeville, PA, USA., Xie F; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Rambo M; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Skedzielewski T; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Hoang B; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Mohanan S; Non-Clinical Safety, IVIVT, GlaxoSmithKline, Collegeville, PA, USA., Comroe D; Integrated Biological Platform Sciences, GlaxoSmithKline, Collegeville, PA, USA., Gehman A; Research Statistics, GlaxoSmithKline, Collegeville, PA, USA., Hsu CY; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Farhangi K; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Tran H; Research Statistics, GlaxoSmithKline, Collegeville, PA, USA., Sherina V; Research Statistics, GlaxoSmithKline, Collegeville, PA, USA., Doan M; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Groseclose MR; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Hopson CB; Immuno-Oncology Research Unit, GlaxoSmithKline, Collegeville, PA, USA., Brett S; Oncology Cell Therapy Research Unit, GlaxoSmithKline, Hertfordshire, UK., Wilson IA; ImaginAb, Inglewood, CA, USA., Nicholls A; Bioimaging, IVIVT, GlaxoSmithKline, Hertfordshire, UK., Ballas M; Oncology Clinical Development, GlaxoSmithKline, Collegeville, PA, USA., Waight JD; Immuno-Oncology Research Unit, GlaxoSmithKline, Collegeville, PA, USA., Jucker BM; Clinical Imaging, GlaxoSmithKline, Collegeville, PA, USA.

المصدر: Molecular imaging and biology [Mol Imaging Biol] 2023 Jun; Vol. 25 (3), pp. 528-540. Date of Electronic Publication: 2022 Oct 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101125610 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-2002 (Electronic) Linking ISSN: 15361632 NLM ISO Abbreviation: Mol Imaging Biol Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes*/pathology , Neoplasms*/pathology, Animals ; Mice ; Female ; Positron Emission Tomography Computed Tomography ; Programmed Cell Death 1 Receptor ; Positron-Emission Tomography/methods ; Immunoglobulin G ; Cell Line, Tumor ; Inducible T-Cell Co-Stimulator Protein

المؤلفون: Valenzuela-Vázquez L; Facultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico.; Instituto de Investigación en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico., Nuñez-Enriquez JC; Unidad de Investigación Médica en Epidemiología Clínica, Unidad Médica de Alta Especialidad (UMAE) Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Sánchez-Herrera J; Facultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico.; Instituto de Investigación en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico., Medina-Sanson A; Servicio de Oncología Pediátrica, Hospital Infantil de México, 'Dr. Federico Gómez Sántos', Secretaria de Salud, Ciudad de México, Mexico., Pérez-Saldivar ML; Unidad de Investigación Médica en Epidemiología Clínica, Unidad Médica de Alta Especialidad (UMAE) Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Jiménez-Hernández E; Servicio de Hematología Pediátrica, Hospital General 'Gaudencio González Garza', Centro Médico Nacional (CMN) 'La Raza', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Martiín-Trejo JA; Servicio de Hematología Pediátrica, Unidad Médica de Alta Especialidad (UMAE) Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Del Campo-Martínez MLÁ; Servicio de Hematología Pediátrica, Hospital General 'Gaudencio González Garza', Centro Médico Nacional (CMN) 'La Raza', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Flores-Lujano J; Unidad de Investigación Médica en Epidemiología Clínica, Unidad Médica de Alta Especialidad (UMAE) Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Amador-Sánchez R; Hospital General Regional No. 1 'Carlos McGregor Sánchez Navarro', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Mora-Ríos FG; Departamento de Hematología, Hospital General Regional Ignacio Zaragoza del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico., Peñaloza-González JG; Servicio de Onco-Pediatria, Hospital Juárez de México, Secretaria de Salud (SS), Mexico City, Mexico., Duarte-Rodríguez DA; Unidad de Investigación Médica en Epidemiología Clínica, Unidad Médica de Alta Especialidad (UMAE) Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Torres-Nava JR; Servicio de Oncología, Hospital Pediátrico de Moctezuma, Secretaría de Salud de la Ciudad de México (CDMX), Mexico City, Mexico., Espinosa-Elizondo RM; Servicio de Hematología Pediátrica, Hospital General de México, Secretaria de Salud (SS), Mexico City, Mexico., Cortés-Herrera B; Servicio de Hematología Pediátrica, Hospital General de México, Secretaria de Salud (SS), Mexico City, Mexico., Flores-Villegas LV; Servicio de Hematología Pediátrica, Centro Médico Nacional (CMN) '20 de Noviembre', Instituto de Seguridad Social al Servicio de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico., Merino-Pasaye LE; Servicio de Hematología Pediátrica, Centro Médico Nacional (CMN) '20 de Noviembre', Instituto de Seguridad Social al Servicio de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico., Almeida-Hernández C; Hospital General de Ecatepec 'Las Américas', Instituto de Salud del Estado de México (ISEM), Mexico City, Mexico., Ramírez-Colorado R; Hospital Pediátrico La Villa, Secretaría de Salud de la Ciudad de México (SSCDMX), Mexico City, Mexico., Solís-Labastida KA; Servicio de Hematología Pediátrica, Unidad Médica de Alta Especialidad (UMAE) Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Medrano-López F; Hospital General Regional (HGR) No. 72 'Dr. Vicente Santos Guajardo', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Pérez-Gómez JA; Hospital General Regional (HGR) No. 72 'Dr. Vicente Santos Guajardo', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Velázquez-Aviña MM; Servicio de Onco-Pediatria, Hospital Juárez de México, Secretaria de Salud (SS), Mexico City, Mexico., Martínez-Ríos A; Departamento de Hematología, Hospital General Regional Ignacio Zaragoza del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico., Aguilar-De Los Santos A; Hospital General de Zona 98, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Santillán-Juárez JD; Servicio de Hemato-oncología Pediátrica, Hospital Regional No. 1° de Octubre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico., Gurrola-Silva A; Hospital Regional Tipo B de Alta Especialidad Bicentenario de la Independencia, Instituto de Seguridad Social al Servicio de los Trabajadores del Estado, Mexico City, Mexico., García-Velázquez AJ; Servicio de Hemato-oncología Pediátrica, Hospital Regional No. 1° de Octubre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico., Mata-Rocha M; Unidad de Investigación Médica en Epidemiología Clínica, Unidad Médica de Alta Especialidad (UMAE) Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Hernández-Echáurregui GA; Servicio de Oncología, Hospital Pediátrico de Moctezuma, Secretaría de Salud de la Ciudad de México (CDMX), Mexico City, Mexico., Sepúlveda-Robles OA; Unidad de Investigación Médica en Genética Humana, Unidad Médica de Alta Especialidad (UMAE) Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Rosas-Vargas H; Unidad de Investigación Médica en Genética Humana, Unidad Médica de Alta Especialidad (UMAE) Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico., Mancilla-Herrera I; Departamento de Infectología e Inmunología, Instituto Nacional de Perinatología, Mexico City, Mexico., Jimenez-Morales S; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico., Hidalgo-Miranda A; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico., Martinez-Duncker I; Centro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico., Waight JD; Oncology R&D, GlaxoSmithKline, Collegeville, PA, United States., Hance KW; Oncology R&D, GlaxoSmithKline, Collegeville, PA, United States., Madauss KP; Oncology R&D, GlaxoSmithKline, Collegeville, PA, United States., Mejía-Aranguré JM; Unidad de Investigación Médica en Genética Humana, Unidad Médica de Alta Especialidad (UMAE) Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.; Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico., Cruz-Munoz ME; Facultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico.

المصدر: Frontiers in oncology [Front Oncol] 2022 Nov 07; Vol. 12, pp. 1023510. Date of Electronic Publication: 2022 Nov 07 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Conner M; Oncology R&D, GlaxoSmithKline, Collegeville, PA, United States., Hance KW; Oncology R&D, GlaxoSmithKline, Collegeville, PA, United States., Yadavilli S; Oncology R&D, GlaxoSmithKline, Collegeville, PA, United States., Smothers J; Oncology R&D, GlaxoSmithKline, Collegeville, PA, United States., Waight JD; Oncology R&D, GlaxoSmithKline, Collegeville, PA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2022 Jun 24; Vol. 13, pp. 914406. Date of Electronic Publication: 2022 Jun 24 (Print Publication: 2022).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy* , Neoplasms*/therapy, Antigens, CD ; Antigens, Differentiation, T-Lymphocyte ; Humans ; Ligands ; Nectins ; Receptors, Immunologic

المؤلفون: Waight JD; Agenus Inc., Lexington, MA, USA., Chand D; Agenus Inc., Lexington, MA, USA., Savitsky DA; Agenus Inc., Lexington, MA, USA.

المصدر: Oncotarget [Oncotarget] 2018 Jul 27; Vol. 9 (58), pp. 31171-31172. Date of Electronic Publication: 2018 Jul 27 (Print Publication: 2018).

نوع المنشور: Editorial

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE

المؤلفون: Waight JD; Agenus Inc., Lexington, MA 02421, USA., Chand D; Agenus Inc., Lexington, MA 02421, USA., Dietrich S; Agenus Inc., Lexington, MA 02421, USA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA., Gombos R; Agenus Inc., Lexington, MA 02421, USA., Horn T; Agenus Inc., Lexington, MA 02421, USA., Gonzalez AM; Agenus Inc., Lexington, MA 02421, USA., Manrique M; Agenus Inc., Lexington, MA 02421, USA., Swiech L; Agenus Inc., Lexington, MA 02421, USA., Morin B; Agenus Inc., Lexington, MA 02421, USA., Brittsan C; Agenus Inc., Lexington, MA 02421, USA., Tanne A; Agenus Inc., Lexington, MA 02421, USA., Akpeng B; Agenus Inc., Lexington, MA 02421, USA., Croker BA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA., Buell JS; Agenus Inc., Lexington, MA 02421, USA., Stein R; Agenus Inc., Lexington, MA 02421, USA., Savitsky DA; Agenus Inc., Lexington, MA 02421, USA. Electronic address: david.savitsky@agenusbio.com., Wilson NS; Agenus Inc., Lexington, MA 02421, USA. Electronic address: nicholas.wilson@gilead.com.

المصدر: Cancer cell [Cancer Cell] 2018 Jun 11; Vol. 33 (6), pp. 1033-1047.e5.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*immunology , Antigen-Presenting Cells/*immunology , Antigens, Differentiation, T-Lymphocyte/*immunology , Receptors, IgG/*immunology, Animals ; Antibodies, Monoclonal/metabolism ; Antibodies, Monoclonal/therapeutic use ; Antigen-Presenting Cells/metabolism ; Antigens, Differentiation, T-Lymphocyte/metabolism ; CTLA-4 Antigen/immunology ; CTLA-4 Antigen/metabolism ; Humans ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Neoplasms/drug therapy ; Neoplasms/immunology ; Neoplasms/metabolism ; Protein Binding ; Receptors, Antigen, T-Cell/immunology ; Receptors, Antigen, T-Cell/metabolism ; Receptors, IgG/metabolism ; Receptors, Immunologic/immunology ; Receptors, Immunologic/metabolism ; Signal Transduction/drug effects ; Signal Transduction/immunology ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism

المؤلفون: Gombos RB; Immuno-modulatory Drug Discovery, Agenus Incorporated, Lexington, Massachusetts, United States of America., Gonzalez A; Immuno-modulatory Drug Discovery, Agenus Incorporated, Lexington, Massachusetts, United States of America., Manrique M; Immuno-modulatory Drug Discovery, Agenus Incorporated, Lexington, Massachusetts, United States of America., Chand D; Immuno-modulatory Drug Discovery, Agenus Incorporated, Lexington, Massachusetts, United States of America., Savitsky D; Immuno-modulatory Drug Discovery, Agenus Incorporated, Lexington, Massachusetts, United States of America., Morin B; Research Biochemistry, Agenus Incorporated, Lexington, Massachusetts, United States of America., Breous-Nystrom E; Agenus Switzerland Incorporated, Basel, Switzerland., Dupont C; Translational Biomarkers, Agenus Incorporated, Lexington, Massachusetts, United States of America., Ward RA; Immuno-modulatory Drug Discovery, Agenus Incorporated, Lexington, Massachusetts, United States of America., Mundt C; Agenus Switzerland Incorporated, Basel, Switzerland., Duckless B; Translational Biomarkers, Agenus Incorporated, Lexington, Massachusetts, United States of America., Tang H; Translational Biomarkers, Agenus Incorporated, Lexington, Massachusetts, United States of America., Findeis MA; Research Biochemistry, Agenus Incorporated, Lexington, Massachusetts, United States of America., Schuster A; Agenus Switzerland Incorporated, Basel, Switzerland., Waight JD; Immuno-modulatory Drug Discovery, Agenus Incorporated, Lexington, Massachusetts, United States of America., Underwood D; Research Biochemistry, Agenus Incorporated, Lexington, Massachusetts, United States of America., Clarke C; Safety, Pharmacology and Toxicology, Agenus Incorporated, Lexington, Massachusetts, United States of America., Ritter G; The Ludwig Institute for Cancer Research, New York, New York, United States of America., Merghoub T; Memorial Sloan Kettering Cancer Center, New York, New York, United States of America., Schaer D; Memorial Sloan Kettering Cancer Center, New York, New York, United States of America., Wolchok JD; Memorial Sloan Kettering Cancer Center, New York, New York, United States of America., van Dijk M; Agenus United Kingdom Limited, Cambridge, United Kingdom., Buell JS; Research and Development Management, Agenus Incorporated, Lexington, Massachusetts, United States of America., Cuillerot JM; Research and Development Management, Agenus Incorporated, Lexington, Massachusetts, United States of America., Stein R; Research and Development Consultant, Agenus Incorporated, Lexington, Massachusetts, United States of America., Drouin EE; Translational Biomarkers, Agenus Incorporated, Lexington, Massachusetts, United States of America., Wilson NS; Immuno-modulatory Drug Discovery, Agenus Incorporated, Lexington, Massachusetts, United States of America.

المصدر: PloS one [PLoS One] 2018 Apr 04; Vol. 13 (4), pp. e0191926. Date of Electronic Publication: 2018 Apr 04 (Print Publication: 2018).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Adjuvants, Immunologic/*pharmacology , Antineoplastic Agents, Immunological/*pharmacology , CTLA-4 Antigen/*immunology , Immunoglobulin G/*pharmacology , Neoplasms/*therapy, Adjuvants, Immunologic/chemistry ; Adjuvants, Immunologic/pharmacokinetics ; Adjuvants, Immunologic/toxicity ; Amino Acid Sequence ; Animals ; Antibody Formation/drug effects ; Antineoplastic Agents, Immunological/chemistry ; Antineoplastic Agents, Immunological/pharmacokinetics ; Antineoplastic Agents, Immunological/toxicity ; CHO Cells ; CTLA-4 Antigen/antagonists & inhibitors ; Cancer Vaccines/pharmacology ; Cells, Cultured ; Cricetulus ; Epitope Mapping ; Humans ; Immunity, Cellular/drug effects ; Immunoglobulin G/chemistry ; Immunoglobulin G/toxicity ; Lymphocyte Activation/drug effects ; Macaca fascicularis ; Models, Molecular ; Neoplasms/immunology ; T-Lymphocytes, Regulatory/drug effects ; T-Lymphocytes, Regulatory/immunology